A Surprising Repurposing of Central Nervous System Drugs against Squamous Cell Carcinoma of the Bladder, UM-UC-5
Open Access
- 31 January 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (2) , 212
Abstract
The potential benefits of drug repurposing have gained attention as an alternative to developing de novo drugs. The potential of using central nervous system (CNS) drugs as anticancer drugs has been explored in several types of human cancers, such as breast and colon cancer, among others. Here, we examine the effect of the CNS drugs sertraline, paroxetine, and chlorpromazine on human squamous carcinoma cells of the bladder (UM-UC-5). After exposing UM-UC-5 cells to increased concentrations of each drug for 48 h, we assessed their metabolic activity using an MTT assay. Based on those results, we calculated cell viability and the half-maximal inhibitory concentration (IC50) values. The results suggest that the CNS drugs were effective against UM-UC-5 in the order of potency of sertraline > chlorpromazine > paroxetine. Interestingly, sertraline was more potent than 5-fluorouracil (5-FU), a widely used anticancer drug. This study demonstrated, for the first time, the promising anticancer activity of CNS drugs on human bladder cancer cells in vitro and supports the repurposing of CNS drugs to improve cancer treatment. Nevertheless, further studies are necessary to understand their mechanism of action and in vivo activity.Keywords
Funding Information
- Fundo Europeu de Desenvolvimento Regional (FEDER) (IF/00092/2014/CP1255/CT0004)
- Fundação para a Ciência e a Tecnologia (FCT) (IF/00092/2014/CP1255/CT0004)
- Faculty of Medicine, University of Porto (FMUP) (IF/00092/2014/CP1255/CT0004)
This publication has 56 references indexed in Scilit:
- The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer DrugsJournal of Clinical Oncology, 2012
- Chlorpromazine activates p21Waf1/Cip1gene transcription via early growth response-1 (Egr-1) in C6 glioma cellsExperimental & Molecular Medicine, 2010
- The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cellsAnti-Cancer Drugs, 2009
- Paroxetine-induced apoptosis in human osteosarcoma cells: Activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevationToxicology and Applied Pharmacology, 2007
- Role of gemcitabine in cancer therapyFuture Oncology, 2005
- Squamous cell carcinoma of the bladder: pathology, diagnosis and treatmentBJU International, 2003
- 5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 2003
- Tyrosine kinase inhibitor imatinib (STIS71) as an anticancer agent for solid tumoursAnnals of Medicine, 2001
- Chlorpromazine transport in membrane vesicles from multidrug resistant CCRF‐CEM cellsIUBMB Life, 1996
- Chlorpromazine: a potential anticancer agent?Biochemical and Biophysical Research Communications, 1984